Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, January 12 '25)

 


    Arch Virol

  1. SAKUMA S, Mine J, Uchida Y, Kumagai A, et al
    Long-term immune responses induced by low-dose infection with high pathogenicity avian influenza viruses can protect mallards from reinfection with a heterologous strain.
    Arch Virol. 2025;170:33.
    PubMed         Abstract available

  2. ARVIA R, Rocca A, Casciato B, Stincarelli MA, et al
    High-resolution melting analysis for detection of nucleotide mutation markers in the polymerase-acidic (PA) gene of influenza virus that are associated with baloxavir marboxil resistance.
    Arch Virol. 2025;170:29.
    PubMed         Abstract available

  3. ASHRAF MA, Raza MA, Imran A, Amjad MN, et al
    Next-generation vaccines for influenza B virus: advancements and challenges.
    Arch Virol. 2025;170:25.
    PubMed         Abstract available

  4. REHMAN Z, Edington K, Jamal Z, Kritz-Wilson A, et al
    The introduction of the SARS-CoV-2 BA.4 lineage into Pakistan.
    Arch Virol. 2025;170:26.
    PubMed         Abstract available


    Biochemistry

  5. LEE E, Rauscher S
    The Conformational Space of the SARS-CoV-2 Main Protease Active Site Loops Is Determined by Ligand Binding and Interprotomer Allostery.
    Biochemistry. 2025;64:32-46.
    PubMed         Abstract available


    BMJ

  6. KAST KA, Sidelnik SA, Nejad SH, Suzuki J, et al
    Management of alcohol withdrawal syndromes in general hospital settings.
    BMJ. 2025;388:e080461.
    PubMed         Abstract available


    Epidemiol Infect

  7. CHANDA MM, Shivachandra SB, Mishra A, Punnoose P, et al
    Unique duck rearing practice in irrigated rice paddy fields driving recurrent H5N1 Avian Influenza outbreaks in two districts of Kerala, India.
    Epidemiol Infect. 2025 Jan 7:1-36. doi: 10.1017/S0950268824001882.
    PubMed        

  8. HUIBERTS AJ, Oosting IJ, de Melker HE, van de Wijgert JHHM, et al
    The effect of SARS-CoV-2 infection and COVID-19 vaccination during pregnancy on neonatal outcomes.
    Epidemiol Infect. 2024;153:e5.
    PubMed         Abstract available


    J Gen Virol

  9. RANDALL RE, Young D, Pisliakova M, Andrejeva J, et al
    Single-cycle parainfluenza virus type 5 vectors for producing recombinant proteins, including a humanized anti-V5 tag antibody.
    J Gen Virol. 2025;106.
    PubMed         Abstract available


    J Infect

  10. MOK CKP, Tang YS, Tan CW, Chong KC, et al
    Comparison of safety and immunogenicity in the elderly after receiving either Comirnaty or Spikevax monovalent XBB1.5 COVID-19 vaccine.
    J Infect. 2024;90:106374.
    PubMed         Abstract available


    J Infect Dis

  11. BILLINGS WZ, Ge Y, Knight JH, Hemme H, et al
    High dose inactivated influenza vaccine inconsistently improves heterologous antibody responses in an elderly human cohort.
    J Infect Dis. 2025 Jan 8:jiaf003. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  12. FOX CR, Yousef NN, Varudkar N, Shiffer EM, et al
    Resistance to complement-mediated lysis of parainfluenza virus 5-infected cells is acquired after transition from acute to persistent infection.
    J Virol. 2025 Jan 10:e0189524. doi: 10.1128/jvi.01895.
    PubMed         Abstract available

  13. PERRY SS, Brice DC, Sakr AA, Kandeil A, et al
    Modulation of cytokeratin and cytokine/chemokine expression following influenza virus infection of differentiated human tonsillar epithelial cells.
    J Virol. 2025 Jan 10:e0146024. doi: 10.1128/jvi.01460.
    PubMed         Abstract available


    PLoS Comput Biol

  14. ABRAHAM AA, Tan ZC, Shrestha P, Bozich ER, et al
    A multivalent binding model infers antibody Fc species from systems serology.
    PLoS Comput Biol. 2024;20:e1012663.
    PubMed         Abstract available

  15. FAJARDO-FONTIVEROS O, Mattei M, Burgio G, Granell C, et al
    Machine learning mathematical models for incidence estimation during pandemics.
    PLoS Comput Biol. 2024;20:e1012687.
    PubMed         Abstract available

  16. ZHANG XY, Yu LL, Wang WY, Sun GQ, et al
    Estimating the time-varying effective reproduction number via Cycle Threshold-based Transformer.
    PLoS Comput Biol. 2024;20:e1012694.
    PubMed         Abstract available

  17. ZUNKER H, Schmieding R, Kerkmann D, Schengen A, et al
    Novel travel time aware metapopulation models and multi-layer waning immunity for late-phase epidemic and endemic scenarios.
    PLoS Comput Biol. 2024;20:e1012630.
    PubMed         Abstract available


    PLoS One

  18. GOLROKHIAN-SANI AA, Morcos M, Philippi A, Al-Rawi R, et al
    Temporal trends in mental health terminology in Alzheimer's disease clinical trials.
    PLoS One. 2024;19:e0310264.
    PubMed         Abstract available

  19. QUINN KL, Stukel TA, Detsky A, Chung H, et al
    Use of virtual care near the end of life before and during the COVID-19 pandemic: A population-based cohort study.
    PLoS One. 2025;20:e0313766.
    PubMed         Abstract available

  20. EVEREST L, Henderson J, Ma C, Prebeg M, et al
    Relationship between mental health and substance abuse on COVID-19 vaccine hesitancy in youth: A mixed methods longitudinal cohort study.
    PLoS One. 2025;20:e0313157.
    PubMed         Abstract available

  21. DZOGAN M, Lacko R, Hajduova Z
    Empirical research of foreign direct investments efficiency in the European Union on the edge of pandemic outbreak.
    PLoS One. 2025;20:e0313161.
    PubMed         Abstract available

  22. TURK F
    Traumatic stress and post-traumatic growth in individuals who have had Covid-19: The mediating effect of resilience and moderating effect of psychological flexibility.
    PLoS One. 2024;19:e0310495.
    PubMed         Abstract available

  23. AMEDEWONU EA, Aryeetey GC, Godi A, Sackeyfio J, et al
    Coping strategies of COVID-19 recovered patients at the Ghana Infectious Disease Centre.
    PLoS One. 2025;20:e0310921.
    PubMed         Abstract available

  24. THONGDEE M, Chaiwattanarungruengpaisan S, Ketchim N, Sangkachai N, et al
    Evidence of avian and human influenza A virus infection in farmed Siamese crocodiles (Crocodylus siamensis) in Thailand.
    PLoS One. 2025;20:e0317035.
    PubMed         Abstract available

  25. HERGOTT M, Andreski M, Rovers J
    Vaccine hesitancy among health paraprofessionals: A mixed methods study.
    PLoS One. 2025;20:e0312708.
    PubMed         Abstract available

  26. SATO Y, Kawachi I, Saijo Y, Yoshioka E, et al
    Correlates of COVID-19 conspiracy theory beliefs in Japan: A cross-sectional study of 28,175 residents.
    PLoS One. 2024;19:e0310673.
    PubMed         Abstract available

  27. PHILLIPS G, Racine E, Naughton AM, Lane J, et al
    Understanding uptake of the COVID-19 vaccination among the homeless: A mixed methods evaluation.
    PLoS One. 2025;20:e0312617.
    PubMed         Abstract available

  28. KRISTENSEN K, Boodram B, Avila W, Pineros J, et al
    Perceptions of access to harm reduction services during the COVID-19 pandemic among people who inject drugs in metropolitan Chicago.
    PLoS One. 2025;20:e0293238.
    PubMed         Abstract available

  29. BRATCHER A, Jones JM, Meyer WA 3rd, Waheed R, et al
    Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions-United States, 2020-2022.
    PLoS One. 2025;20:e0313620.
    PubMed         Abstract available

  30. LAARMAN C, Hahne SJ, de Melker HE, Knol MJ, et al
    SARS-CoV-2 risk factors among symptomatic vaccinated adults attending community testing locations in the Netherlands from June 2021 till February 2022.
    PLoS One. 2024;19:e0311229.
    PubMed         Abstract available

  31. KUMAR V, Golzarri-Arroyo L, Roth S, Imperiale TF, et al
    Effect of the COVID-19 pandemic on colorectal cancer screening in two university-affiliated health care systems.
    PLoS One. 2025;20:e0317057.
    PubMed         Abstract available

  32. WAGNER K, Reinhardt Z, Negash S, Weber L, et al
    University students' health-related quality of life and its determinants. Results from a cross-sectional survey during the COVID-19 pandemic.
    PLoS One. 2025;20:e0310378.
    PubMed         Abstract available

  33. MOHAMMAD KM, Akhi AA, Kamrujjaman M
    Bifurcation analysis of an influenza A (H1N1) model with treatment and vaccination.
    PLoS One. 2025;20:e0315280.
    PubMed         Abstract available

  34. PARRY-NWEYE E, Liu Z, Dhaouadi Y, Guo X, et al
    Persistence of Phi6, a SARS-CoV-2 surrogate, in simulated indoor environments: Effects of humidity and material properties.
    PLoS One. 2025;20:e0313604.
    PubMed         Abstract available

  35. PENG A
    Sustainable regional development from the perspective of economic resilience: Based on the impact of COVID-19.
    PLoS One. 2025;20:e0314663.
    PubMed         Abstract available

  36. KAWAHARA M, Tanaka A
    Impact of partial occlusion of the face on multisensory emotion perception: Comparison of pre- and post-COVID-19 pandemic.
    PLoS One. 2025;20:e0307631.
    PubMed         Abstract available

  37. WHITESIDE C, Klabbers G
    Exploring the perceptions of the effect of the COVID-19 pandemic on the mental well-being and medical education of medical students in Northern Ireland, in addition to the perceived barriers to seeking support; a qualitative study.
    PLoS One. 2025;20:e0314115.
    PubMed         Abstract available

  38. BAKER JM, Nakayama JY, O'Hegarty M, McGowan A, et al
    Household transmission of SARS-CoV-2 in five US jurisdictions: Comparison of Delta and Omicron variants.
    PLoS One. 2025;20:e0313680.
    PubMed         Abstract available

  39. O'NEILL L, Chumbler NR
    Examining the risk of delirium in patients hospitalized with COVID-19: Insights from the homeless population.
    PLoS One. 2025;20:e0313242.
    PubMed         Abstract available

  40. BATISTELLA P, Marca L, Vasconcellos FCF, Sanguinet ER, et al
    Determinants of agricultural employment during the COVID-19 pandemic: A spatial analysis of Brazilian municipalities.
    PLoS One. 2025;20:e0316489.
    PubMed         Abstract available

  41. DROST M, Loibl C, Snyder A, Betz M, et al
    The association of financial resources and loneliness among older adults during a state of emergency.
    PLoS One. 2025;20:e0314042.
    PubMed         Abstract available

  42. GRASSI M, Tarantino B
    SEMdag: Fast learning of Directed Acyclic Graphs via node or layer ordering.
    PLoS One. 2025;20:e0317283.
    PubMed         Abstract available

  43. DOMNICH A, Trombetta CS, Fallani E, Salvatore M, et al
    Immunogenicity and safety of the MF59-adjuvanted seasonal influenza vaccine in non-elderly adults: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0310677.
    PubMed         Abstract available

  44. LENIZ J, Hernandez-Jana S, Soto M, Arenas E, et al
    Association between demographic, clinical characteristics and severe complications by SARS-CoV-2 infection in a community-based healthcare network in Chile.
    PLoS One. 2024;19:e0314376.
    PubMed         Abstract available

  45. BARRETO TO, Farias FLO, Veras NVR, Cardoso PH, et al
    Artificial intelligence applied to bed regulation in Rio Grande do Norte: Data analysis and application of machine learning on the "RegulaRN Leitos Gerais" platform.
    PLoS One. 2024;19:e0315379.
    PubMed         Abstract available

  46. BARNES SJ, Na Y, Drainoni ML, Linas BA, et al
    Barriers and facilitators to conducting human subjects research at a safety net institution from the perspective of researchers.
    PLoS One. 2025;20:e0313530.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  47. SCHULZ S, Tan TJC, Wu NC, Wang S, et al
    Epistatic hotspots organize antibody fitness landscape and boost evolvability.
    Proc Natl Acad Sci U S A. 2025;122:e2413884122.
    PubMed         Abstract available

  48. SINGH R, Im C, Qiu Y, Mackness B, et al
    Learning the language of antibody hypervariability.
    Proc Natl Acad Sci U S A. 2025;122:e2418918121.
    PubMed         Abstract available


    Vaccine

  49. EL SAHLY HM, Anderson EJ, Jackson LA, Neuzil KM, et al
    Anti-neuraminidase and anti-hemagglutinin stalk responses to different influenza a(H7N9) vaccine regimens.
    Vaccine. 2025;47:126689.
    PubMed         Abstract available


    Virus Res

  50. DEZORDI FZ, Junior JVJS, Ruoso TF, Batista AG, et al
    Higher frequency of interstate over international transmission chains of SARS-CoV-2 virus at the Rio Grande do Sul - Brazil state borders.
    Virus Res. 2025;351:199500.
    PubMed         Abstract available

  51. EL HOUDI M, Skhoun H, El Fessikh M, Benmansour R, et al
    Association study of the JAK/STAT signaling pathway with susceptibility to COVID-19 in moroccan patient and in-silico analysis of rare variants.
    Virus Res. 2025;351:199509.
    PubMed         Abstract available

Comments

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...